FDA Alert News from Psych Central News

First ADHD Add-On Drug Approved

Thursday, October 7th, 2010

The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used to treat attention deficit hyperactivity disorder (ADHD) that can be used ...

Read more... »

FDA Warns of Potential Meningitis Risk Associated with Lamictal

Saturday, August 14th, 2010

A new side effect associated with the psychiatric medication Lamictal has been discovered. On August 12th the U.S. Food and Drug Administration (FDA) issued a new warning that Lamictal (lamotrigine) has a very low risk of causing a condition ...

Read more... »

Female Viagra Ineffective

Monday, June 21st, 2010

After much review and public controversy, the FDA met this week and determined that flibanserin, a new medication that was hoped to be an effective treatment for female sexual arousal disorder, did not ...

Read more... »

FDA Approves Zyprexa for Schizophrenia, Bipolar Disorder in Teens

Saturday, December 5th, 2009

The U.S. Food and Drug Administration (FDA) handed Eli Lilly & Co. approval to market its best-selling medication ...

Read more... »

FDA Warns Pregnant Women Taking Depakote, Depakene

Saturday, December 5th, 2009

The U.S. Food and Drug Administration (FDA) last week notified health care professionals and patients about ...

Read more... »

Seroquel Gains FDA Approvals for Add-on Depression Treatment, Pediatric Schizophrenia

Saturday, December 5th, 2009

The U.S. Food and Drug Administration (FDA) announced this past week that two types of Seroquel-brand (quetiapine ...

Read more... »

New Treatment for Schizophrenia and Bipolar Disorder

Friday, August 14th, 2009

The U.S. Food and Drug Administration (FDA) has approved Saphris tablets (asenapine) to treat adults with schizophrenia or bipolar disorder. "Mental illnesses ...

Read more... »

Invega Antipsychotic Approved for Schizophrenia, Schizoaffective Disorder

Thursday, August 6th, 2009

Last week, the U.S. Food and Drug Administration (FDA) handed down two new approvals for Invega (paliperidone), an atypical antipsychotic medication, ...

Read more... »